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Stroke is responsible for a large part of the global burden of dis-
ease. Worldwide in 1990 it was the second commonest cause of 
mortality, causing approximately 4.4 million deaths. Two-thirds 
of these deaths occurred in less developed countries. In South 
Africa in 2001 it was the fourth leading reported natural cause 
of mortality.1 
HIV infection has in the wake of our pandemic become a 
leading cause of death and dread disease, with an estimated 
15% of the population being infected.1
A co-occurrence of these two illnesses is therefore expected. 
The debate rests with regard to whether or not there is a causal 
relationship.2 
The first suggestion that there is an association between 
HIV and stroke came from autopsy and case series from the 
USA.2 These were followed by population studies to deter-
mine the risk of this association.2 The first of these was a study 
from KwaZulu-Natal (KZN) that found an HIV prevalence of 
16% in a young stroke population.2 The prevalence of HIV in 
that region at that time was also 16%, suggesting that there 
was no significant increase in the risk of stroke associated 
with HIV infection. In another population-based study from 
Baltimore, USA, the incidence of stroke in persons with AIDS 
was 0.2% per year.2 In this study AIDS was found to confer an 
adjusted relative risk of 13.7 for ischaemic stroke (IS) and 25.5 
for intracerebral haemorrhage (ICH), indicating that AIDS is 
strongly associated with both IS and ICH.2 A criticism directed 
at this study has been that only patients meeting the Centers 
for Disease Control (CDC) definition of AIDS were included. In 
a study from Germany on 772 HIV-infected patients, a preva-
lence of 1.2% for stroke and an annual incidence rate for IS of 
216/100 000 population was reported.2 The prevalence was 
highest in young adult patients with advanced HIV infection.2 
This latter finding has been consistently observed in studies 
reporting on the association between HIV and stroke. The re-
sults in this regard thus appear to be inconclusive but favour an 
increased stroke risk, at least with advanced HIV/AIDS.
These studies and subsequent clinical case series identified 
the potential causes or mechanisms of stroke in HIV infection 
to be opportunistic infections, intracranial neoplasms, marantic 
and infective endocarditis, and coagulation abnormalities.2 In 
a prospective study carried out by us at Chris Hani Baragwa-
nath Hospital we found the causes of stroke in HIV-infected 
patients to be coagulopathies (42%), meningitis (22%), vascu-
lopathy (10%), cardioembolism (7%), hypertension (7%) and 
cryptogenic (12%).3 The specific coagulopathy linked to stroke 
in HIV is protein S deficiency but, as we later showed, this is an 
epiphenomenon of HIV rather than a cause of stroke.3 Several 
other studies from various regions of the world, including 
Baltimore (USA), KZN and Blantyre (Malawi), reporting on the 
mechanisms of stroke in HIV obtained results similar to ours.2,3 
These findings are, however, comparable to the causes/mecha-
nisms of stroke reported in HIV-negative patients, arguing once 
again in favour of a coincidental rather than causal association 
between HIV and stroke.3 
In terms of these causes/mechanisms, hypertension, men-
ingitis, cardioembolism and coagulopathies are associated 
with stroke in HIV-infected patients in the same manner as is 
described for HIV-negative patients. Vasculitis deserves further 
mention as it is often empirically or anecdotally described to 
be a cause/mechanism of stroke in HIV- infected patients, even 
though vasculitis caused by HIV has yet to be identified in the 
brain.4 Vasculitis, when identified in patients with HIV and 
stroke, is most often due to an underlying or associated op-
portunistic infection. Vasculopathy, on the other hand, is used 
to describe involvement of arterial vessels by HIV itself, in the 
absence of opportunistic infection, aneurysm formation and 
inflammatory immune diseases, and has been identified at au-
topsy in HIV-infected brains, antemortem in children with HIV 
and even in a murine AIDS model.4,5 Whether or not this vascu-
lopathy causes stroke in HIV has yet to be proven. Aneurysmal 
vasculopathy has been described in HIV, albeit infrequently. 
The aneurysms occur intracranially and extracranially, are 
mostly fusiform, and present with subarachnoid haemorrhage 
and rarely with ischaemic stroke.5
Antiretrovirals (ARVs) are being increasingly used in our 
health care systems and in terms of toxicity or side-effects 
have now become topical with respect to being potential risk 
factors for cardiovascular and cerebrovascular disease. ARVs 
are expected to increase the burden of stroke and heart attack 
in HIV. ARVs, in particular the protease inhibitors, cause a 
metabolic syndrome characterised by lipodystrophy/lipoatro-
phy, abnormal body fat distribution, dyslipidaemia and insulin 
resistance.6 These are associated with endothelial dysfunction. 
Endothelial dysfunction is a critical initial step of atherogenesis 
that subsequently contributes to the progression and clinical 
manifestations of atherosclerosis.6 It is therefore pivotal to the 
development of cardiovascular and inflammatory pathology.6 
Whereas there are recent reports of myocardial infarction in 
young patients receiving protease inhibitor therapy, such evi-
dence with respect to cerebrovascular disease or stroke is still 
lacking. Furthermore, endothelial dysfunction has been seen 
in HIV-infected patients without the use of ARVs. Endothelial 
activation in HIV is thought to occur either by cytokines or 
by the effects of secreted HIV-associated proteins, gp120 and 
TAT. The dysfunctional endothelial cells could then potentiate 
tissue injury, inflammation and remodelling and accelerate the 
development of cardiovascular and cerebrovascular disease.6 
The question therefore arises as to whether endothelial dysfunc-
tion, and the consequent vasculopathy or potential to accelerate 
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atherosclerosis, are clinically relevant or merely epiphenomena. 
Case control studies that identify vasculopathies and investi-
gate endothelial function and atherogenicity in HIV-infected 
patients with and without stroke are needed to resolve these 
issues. 
ICH as a cause of stroke in HIV patients is reported infre-
quently but is thought to be higher than would be expected in 
a general population of young adults with stroke.7 ICH is a late 
and serious complication of AIDS with a mortality of 62.5%. Po-
tential aetiologies for the ICH that have been described include 
cerebral toxoplasmosis, thrombocytopenia, hypertension and 
cerebral tuberculosis.7 
Cerebral venous thrombosis is a relatively important cause of 
stroke in the young, but despite the high occurrence of coagula-
tion disorders, has not been widely reported in HIV-associated 
stroke. 
In conclusion, the evidence from the literature with respect to 
stroke and HIV is that:
1. There is a probable increased risk for stroke in young 
adults with advanced HIV infection.
2. The causes/mechanisms of stroke in HIV are similar to 
those in non-HIV stroke populations.
3. Infections presenting as meningitis or a focal brain lesion 
or causing vasculitis need to be identified and treated. The most 
pertinent investigations are brain imaging and cerebrospinal 
fluid analysis – an important issue in resource-limited settings 
that currently bear the brunt of the HIV epidemic.
4. The introduction of ARVs may increase the risk of stroke in 
HIV.
5. The molecular mechanism/s of stroke in HIV are yet to be 
elucidated. 
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